US trial for Cook's TAA (thoracic aortic aneurysms) graft
This article was originally published in Clinica
Executive Summary
US researchers are investigating the use of the Cook Group's endovascular medical device for treating thoracic aortic aneurysms (TAA). Based at the Hospital of the University of Pennsylvania (HUP), the STARZ-TX2 trial will enrol 275 patients and include up to 35 institutions in the US and Canada.